News

Filter

Current filters:

GlaxoSmithKline

201 to 210 of 97565 results

Qiagen acquires unit of Enzymatics and agrees partnership with ArcherDX

Qiagen acquires unit of Enzymatics and agrees partnership with ArcherDX

12-01-2015

Netherlands-based company Qiagen has acquired the Enzyme Solutions Unit of privately-held US company…

ArcherDXBiotechnologyEnzymaticsGeneticsMergers & AcquisitionsNetherlandsQiagen

US insurance firm Anthem chooses Gilead’s Harvoni as primary HCV drug

US insurance firm Anthem chooses Gilead’s Harvoni as primary HCV drug

12-01-2015

US biotech major Gilead Sciences has signed an agreement with US health insurance firm Anthem to provide…

Anti-viralsGileadHarvoniPharmaceuticalPricingUSA

AbbVie issues earnings-per-share guidance up 30% for 2015

AbbVie issues earnings-per-share guidance up 30% for 2015

12-01-2015

US drugmaker AbbVie has issued updated guidance about its expected earnings in 2015.

AbbVieAnti-viralsFinancialHumiraPharmaceuticalUSAViekira Pak

US Senators reintroduce bill to allow cheaper drug imports from Canada

12-01-2015

US Senators Amy Klobuchar (Democrat, Minnesota) and John McCain (Republican, Arizona) last week resumed…

CanadaLegalPharmaceuticalPoliticsUSA

China’s FDA approves Chipscreen’s Epidaza

China’s FDA approves Chipscreen’s Epidaza

12-01-2015

Chinese biotech firm Chipscreen Biosciences has received regulatory approval of Epidaza (chidamide),…

BiotechnologychidamideChinaChipscreen BiosciencesEpidazaOncologyRegulation

Esteve could earn $1 billion from pain partnership with Mundipharma and Purdue

Esteve could earn $1 billion from pain partnership with Mundipharma and Purdue

12-01-2015

Swiss drugmaker Mundipharma Laboratories and its independent associated company, Purdue Pharmaceuticals,…

E-52862E-58425Esteve GroupLicensingMundipharmaNeurologicalPharmaceuticalPurdue PharmaResearch

Shire to spend $5.2 billion to buy NPS Pharma

Shire to spend $5.2 billion to buy NPS Pharma

12-01-2015

Recently jilted Ireland-headquartered Shire says it is to acquire NPS Pharmaceuticals, confirming recent…

BiotechnologyEuropeGattexMergers & AcquisitionsNatparaNPS PharmaceuticalsRare diseasesRevestiveShire

KaloBios president and chief executive David Pritchard retires

KaloBios president and chief executive David Pritchard retires

11-01-2015

KaloBios Pharmaceuticals has announced its president and chief executive, David Pritchard, is to retire.

BoardroomBusiness FinanceKaloBios PharmaceuticalsPharmaceuticalPresident and chief executiveUSA

EMA backs record number of drugs for rare diseases in 2014

EMA backs record number of drugs for rare diseases in 2014

11-01-2015

The European Medicines Agency recommended the highest number of orphan designated medicines for marketing…

CyramzaEuropeGazyvaroHoloclarImbruvicaMekinistPharmaceuticalRegulationScenesseTranslarna

201 to 210 of 97565 results

Back to top